ChatGPT’s higher scores and shorter, more focused responses indicate that it may be a more efficient tool for addressing breast cancer–related patient questions, and Gemini’s acceptable overall performance demonstrates acceptable overall performance.
Abstract
Background Breast cancer, the most common malignancy among women, remains a major global public health concern. With the rapid growth of artificial intelligence–based language models, it is essential to evaluate their potential roles in patient education. This study compared ChatGPT and Gemini in responding to patient-oriented questions about breast cancer and its surgical treatment regarding scientific accuracy, clarity, and unnecessary detail. Methods Forty frequently asked questions were collected from Turkish online sources. Both models were queried under identical conditions on August 13, 2025, and the responses were anonymized for blinded evaluation. Four general surgeons experienced in breast surgery independently assessed each response using a five-point Likert scale across three domains: scientific accuracy, clarity, and unnecessary detail. Results Response lengths were recorded and compared. ChatGPT achieved significantly higher median scores than Gemini in scientific accuracy [4.75 (3.50–5.00) vs. 4.25 (3.50–5.00); p < 0.001], clarity [4.75 (3.50–5.00) vs. 4.25 (3.25–5.00); p = 0.005], and unnecessary detail [5.00 (5.00–5.00) vs. 4.50 (3.50–5.00); p < 0.001]. The overall median score was 4.83 (4.08–5.00) for ChatGPT and 4.33 (3.50–4.92) for Gemini (p < 0.001). Gemini’s responses were significantly longer (244 ± 84 vs. 170 ± 47 words; p < 0.001). Conclusion Both models demonstrated acceptable overall performance. However, ChatGPT’s higher scores and shorter, more focused responses indicate that it may be a more efficient tool for addressing breast cancer–related patient questions. In their current form, these models should not be used for diagnostic or clinical decision-making purposes. AI-generated health information should be used only under expert supervision and for educational or supportive purposes.
IntroductionPatients are increasingly turning to large language models (LLMs) such as ChatGPT for medical guidance, prompting concerns around medical competence. This study assesses the proficiency of ChatGPT 4.o in answering patient questions regarding the surgical management of colon and rectal cancer.MethodsChatGPT...
Alyssa Habermann, Tania Gupta, S. Cohen et al.· Surgical Innovation· 0 citations
OBJECTIVE
To evaluate the quality of responses from four publicly available LLMs (ChatGPT-4o, Claude 3.7, Gemini 2.5, and Copilot) to frequently asked questions (FAQs) in pediatric urology.
METHODS
FAQs were generated using standardized prompts and submitted to each LLM using parent-centered instructions. Two board-c...
Najva Mazhari, Andrew Freedman, Nadine A. Friedrich et al.· Urology· 0 citations
Public-facing chatbots may support general patient education but should not replace individualized clinician-led prognostic communication as public-facing chatbots differed substantially in safety, reliability, communication quality, and readability.
Yan-Ru Jiang, Qian-Yun Wang, Liang Zheng et al.· Frontiers in Public Health· 0 citations
Evaluating the reliability and readability of the responses generated by four mainstream LLMs to questions related to oral cancer found no model showed consistently high performance across all dimensions or met recommended readability standards.
Bo Zhang, Weidi Shi, Ying Zhang· Oral Health & Preventive Den...· 0 citations
No single model outperformed the others in all the test areas, so many different LLMs were chosen to provide support for breast cancer health information.
Gemini significantly outperforms ChatGPT in response quality, reliability, and linguistic accessibility for breast cancer education, however, both models exceed the recommended sixth-grade reading level, indicating suboptimal optimization for general health literacy.
Burak Altunpak· Surgical Innovation· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.